Semaglutide Subcutaneous Injection

DRUG2 trials

Sponsors

Beijing Chao Yang Hospital, Shanghai Fengxian District Central Hospital

Conditions

ObesitySleep Apnea Syndrome (OSAS)

Unknown Phase

Semaglutide's Weight Loss Effects in Obesity

Not yet recruitingNCT06825793

Beijing Chao Yang HospitalObesity

Start: 2025-02-20End: 2027-12-31Target: 56Updated: 2025-02-13

Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea

CompletedNCT07281196

Shanghai Fengxian District Central HospitalSleep Apnea Syndrome (OSAS)

Start: 2025-01-01End: 2026-01-31Updated: 2026-04-20